Harry L. Leider - 19 Dec 2023 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Chief Executive Officer, Director
Signature
/s/ Harry L. Leider
Issuer symbol
ZEOX
Transactions as of
19 Dec 2023
Net transactions value
-$6,901
Form type
4
Filing time
20 Dec 2023, 16:05:26 UTC
Previous filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $6,901 -5,248 -100% $1.32 0 19 Dec 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares disposed of were held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.